MA39027B1 - Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu'agents neurogènes dans le traitement des troubles neurodégénératifs - Google Patents
Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu'agents neurogènes dans le traitement des troubles neurodégénératifsInfo
- Publication number
- MA39027B1 MA39027B1 MA39027A MA39027A MA39027B1 MA 39027 B1 MA39027 B1 MA 39027B1 MA 39027 A MA39027 A MA 39027A MA 39027 A MA39027 A MA 39027A MA 39027 B1 MA39027 B1 MA 39027B1
- Authority
- MA
- Morocco
- Prior art keywords
- pyrido
- pyrazine
- treatment
- neurodegenerative disorders
- neurogenic agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
Abstract
L'invention concerne des composés de formule générale (i), dans laquelle r
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13192406 | 2013-11-12 | ||
PCT/EP2014/073988 WO2015071178A1 (fr) | 2013-11-12 | 2014-11-07 | Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu'agents neurogènes dans le traitement des troubles neurodégénératifs |
Publications (2)
Publication Number | Publication Date |
---|---|
MA39027A1 MA39027A1 (fr) | 2018-05-31 |
MA39027B1 true MA39027B1 (fr) | 2018-10-31 |
Family
ID=49552255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39027A MA39027B1 (fr) | 2013-11-12 | 2014-11-07 | Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu'agents neurogènes dans le traitement des troubles neurodégénératifs |
Country Status (18)
Country | Link |
---|---|
US (1) | US9670206B2 (fr) |
EP (1) | EP3068781B1 (fr) |
JP (1) | JP6229056B2 (fr) |
KR (1) | KR101861937B1 (fr) |
CN (1) | CN105764901B (fr) |
AU (1) | AU2014350371B2 (fr) |
CA (1) | CA2929461A1 (fr) |
CL (1) | CL2016001024A1 (fr) |
CR (1) | CR20160142A (fr) |
EA (1) | EA028940B1 (fr) |
HK (1) | HK1223916A1 (fr) |
IL (1) | IL244619A0 (fr) |
MA (1) | MA39027B1 (fr) |
MX (1) | MX2016006052A (fr) |
PE (1) | PE20160692A1 (fr) |
PH (1) | PH12016500605A1 (fr) |
UA (1) | UA117041C2 (fr) |
WO (1) | WO2015071178A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017072039A1 (fr) | 2015-10-26 | 2017-05-04 | Bayer Cropscience Aktiengesellschaft | Dérivés hétérocycles bicycliques condensés utilisés en tant que produits de lutte antiparasitaire |
CA3108099A1 (fr) * | 2018-07-31 | 2020-02-06 | Merck Patent Gmbh | Antagonistes de tlr7/8 et leurs utilisations |
US20220204499A1 (en) | 2019-02-26 | 2022-06-30 | Bayer Aktiengesellschaft | Condensed bicyclic heterocyclic derivatives as pest control agents |
MX2021010215A (es) | 2019-02-26 | 2021-09-21 | Bayer Ag | Derivados de heterociclos biciclicos fusionados como pesticidas. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7282506B2 (en) * | 2004-08-03 | 2007-10-16 | Serenex, Inc. | 2,8-disubstituted naphthyridine derivatives |
CN101356173B (zh) * | 2005-11-11 | 2012-10-31 | 阿特纳赞塔里斯有限公司 | 新的吡啶并吡嗪和它们作为激酶调节剂的用途 |
US9095572B2 (en) * | 2009-01-09 | 2015-08-04 | Board Of Regents Of The University Of Texas System | Pro-neurogenic compounds |
BRPI1011477A2 (pt) * | 2009-03-02 | 2016-03-22 | Sirtris Pharmaceuticals Inc | quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina |
BRPI1013545A2 (pt) * | 2009-04-22 | 2019-09-24 | Janssen Phamaceutica N V | azetidinil diamidas como inibidores de monoacilglicerol lipase |
JP6113354B2 (ja) * | 2013-05-03 | 2017-04-12 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 神経新生刺激イソキノリン誘導体 |
TWI529171B (zh) * | 2013-07-29 | 2016-04-11 | 赫孚孟拉羅股份公司 | 1,7-萘啶衍生物 |
-
2014
- 2014-11-07 MX MX2016006052A patent/MX2016006052A/es unknown
- 2014-11-07 WO PCT/EP2014/073988 patent/WO2015071178A1/fr active Application Filing
- 2014-11-07 KR KR1020167012464A patent/KR101861937B1/ko active IP Right Grant
- 2014-11-07 CN CN201480061521.6A patent/CN105764901B/zh not_active Expired - Fee Related
- 2014-11-07 UA UAA201606256A patent/UA117041C2/uk unknown
- 2014-11-07 CA CA2929461A patent/CA2929461A1/fr not_active Abandoned
- 2014-11-07 EP EP14796743.4A patent/EP3068781B1/fr not_active Not-in-force
- 2014-11-07 AU AU2014350371A patent/AU2014350371B2/en not_active Ceased
- 2014-11-07 EA EA201690971A patent/EA028940B1/ru not_active IP Right Cessation
- 2014-11-07 MA MA39027A patent/MA39027B1/fr unknown
- 2014-11-07 PE PE2016000545A patent/PE20160692A1/es unknown
- 2014-11-07 JP JP2016530137A patent/JP6229056B2/ja not_active Expired - Fee Related
-
2016
- 2016-03-16 IL IL244619A patent/IL244619A0/en unknown
- 2016-03-29 CR CR20160142A patent/CR20160142A/es unknown
- 2016-04-04 PH PH12016500605A patent/PH12016500605A1/en unknown
- 2016-04-29 CL CL2016001024A patent/CL2016001024A1/es unknown
- 2016-05-11 US US15/151,698 patent/US9670206B2/en not_active Expired - Fee Related
- 2016-10-19 HK HK16112041.6A patent/HK1223916A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2016536320A (ja) | 2016-11-24 |
EA028940B1 (ru) | 2018-01-31 |
CN105764901A (zh) | 2016-07-13 |
UA117041C2 (uk) | 2018-06-11 |
HK1223916A1 (zh) | 2017-08-11 |
KR20160061427A (ko) | 2016-05-31 |
CL2016001024A1 (es) | 2016-11-18 |
IL244619A0 (en) | 2016-04-21 |
JP6229056B2 (ja) | 2017-11-08 |
CR20160142A (es) | 2016-05-04 |
US20160251355A1 (en) | 2016-09-01 |
PE20160692A1 (es) | 2016-07-28 |
PH12016500605A1 (en) | 2016-06-13 |
MX2016006052A (es) | 2016-07-18 |
EP3068781B1 (fr) | 2017-12-20 |
MA39027A1 (fr) | 2018-05-31 |
AU2014350371B2 (en) | 2018-02-15 |
US9670206B2 (en) | 2017-06-06 |
KR101861937B1 (ko) | 2018-05-28 |
EP3068781A1 (fr) | 2016-09-21 |
EA201690971A1 (ru) | 2016-08-31 |
WO2015071178A1 (fr) | 2015-05-21 |
CN105764901B (zh) | 2018-06-22 |
CA2929461A1 (fr) | 2015-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA37959A2 (fr) | Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih | |
MA37943B1 (fr) | 2-oxo-2,3-dihydro-indoles destinés au traitement de troubles du snc | |
EA201691070A1 (ru) | Новые трициклические соединения в качестве противораковых средств | |
MA35926B1 (fr) | Pyrrolidine-2-carboxamides substitués | |
MA35049B1 (fr) | Triazolopyridines | |
MA38922A2 (fr) | Dérivés de quinolizine substitués utiles en tant qu'inhibiteurs de l'integrase du vih | |
MA39985B1 (fr) | 1h-pyrrolo [2,3-c]pyridine -7(6h)-ones et pyrazolo[3,4-c]pyridine-7(6h)-ones en tant qu'inhibiteurs de protéines bet | |
MA38333A1 (fr) | Composés d'azabenzimidazole en tant qu'inhibiteurs d'isozymes pde4 pour le traitement de troubles du snc et d'autres affections | |
MA35096B1 (fr) | Cyclopropylamines en tant qu'inhibiteurs de lsd1 | |
MA37866A1 (fr) | Dérivés de type aza-indazole ou diaza-indazole pour le traitement de la douleur | |
GEP201706659B (en) | Novel bicyclic pyridinones | |
MA47356A1 (fr) | Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases | |
EA201400976A1 (ru) | Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена | |
MX2016007128A (es) | Compuestos del receptor 6 de quimiocina (ccr6). | |
IN2014MN00697A (fr) | ||
MA39171A1 (fr) | Dérivés d'hydroxy formamide et leur utilisation | |
MA39027A1 (fr) | Pyrido[4,3-b]pyrazine-2-carboxamides utilisées en tant qu'agents neurogènes dans le traitement des troubles neurodégénératifs | |
WO2012104823A3 (fr) | Composés pyridopyrimidinones dans le traitement de maladies neurodégénératives | |
MA34578B1 (fr) | Composés de tétrahydrofuranyl disubstitués en tant qu'antagonistes du récepteur de la bradykinine b1 | |
MA35742B1 (fr) | Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques | |
MX2019011265A (es) | Derivados del acido acetico azaindol y su uso como moduladores de receptor de prostaglandina d2. | |
MA38010B1 (fr) | Dérivés d'éthynyl utilisés en tant que modulateurs de l'activité des récepteurs mglur5 | |
MA20150280A2 (fr) | Dérivés d'aryléthynyle | |
MA37999B1 (fr) | Dérivés de macrolide, leur préparation et leur utilisation thérapeutique | |
MX2016011900A (es) | Derivados de acido azaindol-acetico y su uso como moduladores del receptor de prostaglandina d2. |